• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

solid tumors

GammaDelta Therapeutics.
Posted inMergers & Acquisitions, Oncology

Takeda Bets on Promising Gamma Delta T-cell Immunotherapy

October 28, 2021September 8, 2022

UK-based GammaDelta Therapeutics has developed a pipeline of novel allogeneic cell therapies.

Cancer.
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory

Danyelza: New Drug for Neuroblastoma That Can Cure It

April 16, 2021September 8, 2022

Naxitamab by Y-mAbs Therapeutics offers gorgeous treatment efficacy with unsafe adverse events.

Pills.
Posted inOncology, Research

Not All Cancer Drugs Are Equally Useful

April 3, 2021September 8, 2022

Cheating out of ignorance, or Sleight of hand and no fraud. How pharmaceutical companies scam clinical trials.

BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News